Neratinib

別名:HKI-272

Neratinib is a highly selective HER2 and EGFR inhibitor with IC50 of 59 nM and 92 nM in cell-free assays; weakly inhibits KDR and Src, no significant inhibition to Akt, CDK1/2/4, IKK-2, MK-2, PDK1, c-Raf and c-Met. Phase 3.

Neratinib化学構造

CAS No. 698387-09-6

サイズ 価格(税別) 在庫状況
JPY 16300 国内在庫あり
JPY 39100 国内在庫あり
JPY 89900 国内在庫あり

代表番号: 045-509-1970|電子メール:[email protected]
よく尋ねられる質問

文献中Selleckの製品使用例(97)

製品安全説明書

現在のバッチを見る: 純度: 99.94%
99.94

Neratinib関連製品

シグナル伝達経路

HER2阻害剤の選択性比較

Cell Data

Cell Lines Assay Type Concentration Incubation Time 活性情報 PMID
SKBR Growth Inhibition Assay 0.01-100 nM 3-7 d inhibits cell growth in time and dose dependent manner 21487605
Sf9 Function assay 10 mins Inhibition of human wild type EGFR expressed in Sf9 cells using [gamma32P]-ATP after 10 mins by scintillation counting, IC50 = 0.0025 μM. 24900643
Sf9 Function assay 10 mins Inhibition of human EGFR T790M/L858R mutant expressed in Sf9 cells using [gamma32P]-ATP after 10 mins by scintillation counting, IC50 = 0.066 μM. 24900643
BAF3 Function assay 72 hrs Inhibition of Tel-fused IGF1R (unknown origin) expressed in mouse BAF3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo assay, GI50 = 0.19 μM. 28282122
BAF3 Function assay 72 hrs Inhibition of Tel-fused INSR (unknown origin) expressed in mouse BAF3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo assay, GI50 = 0.29 μM. 28282122
BAF3 Growth inhibition assay 72 hrs Growth inhibition of mouse BAF3 cells after 72 hrs by CellTiter-Glo assay, GI50 = 1.9 μM. 28282122
SKBR3 Growth Inhibition Assay IC50=0.0075 ± 0.005 μM 23816254
BT474 Growth Inhibition Assay IC50=0.00323 ± 0.00075 μM 23816254
CAL-51 Growth Inhibition Assay IC50=1.89 μM 24009064
KPL-1 Growth Inhibition Assay IC50=1.89 μM 24009064
BT-549 Growth Inhibition Assay IC50=1.14 μM 24009064
MDA-MB-157 Growth Inhibition Assay IC50=1.12 μM 24009064
MDA-MB-231 Growth Inhibition Assay IC50=1.00 μM 24009064
UACC-732 Growth Inhibition Assay IC50=0.65 μM 24009064
HCC1143 Growth Inhibition Assay IC50=0.54 μM 24009064
HCC1937 Growth Inhibition Assay IC50=0.50 μM 24009064
HCC1395 Growth Inhibition Assay IC50=0.49 μM 24009064
HCC1806 Growth Inhibition Assay IC50=0.44 μM 24009064
MDA-MB-415 Growth Inhibition Assay IC50=0.42 μM 24009064
MCF-7 Growth Inhibition Assay IC50=0.41 μM 24009064
MDA-MB-436 Growth Inhibition Assay IC50=0.41 μM 24009064
CAMA-1 Growth Inhibition Assay IC50=0.37 μM 24009064
MDA-MB-468 Growth Inhibition Assay IC50=0.33 μM 24009064
MDA-MB-435 Growth Inhibition Assay IC50=0.33 μM 24009064
HCC38 Growth Inhibition Assay IC50=0.25 μM 24009064
MDA-MB-134 Growth Inhibition Assay IC50=0.17 μM 24009064
T-47D Growth Inhibition Assay IC50=0.16 μM 24009064
EFM-19 Growth Inhibition Assay IC50=0.11 μM 24009064
HCC1187 Growth Inhibition Assay IC50=0.10 μM 24009064
MDA-MB-453 Growth Inhibition Assay IC50=0.09 μM 24009064
BT-20 Growth Inhibition Assay IC50=0.07 μM 24009064
HCC70 Growth Inhibition Assay IC50=0.03 μM 24009064
ZR-75-1 Growth Inhibition Assay IC50=0.03 μM 24009064
SUM-190 Growth Inhibition Assay IC50=0.01 μM 24009064
SUM-225 Growth Inhibition Assay IC50=0.01 μM 24009064
UACC-893 Growth Inhibition Assay IC50<0.005 μM 24009064
UACC-812 Growth Inhibition Assay IC50<0.005 μM 24009064
SK-BR-3 Growth Inhibition Assay IC50<0.005 μM 24009064
MDA-MB-361 Growth Inhibition Assay IC50<0.005 μM 24009064
MDA-MB-175 Growth Inhibition Assay IC50<0.005 μM 24009064
HCC1954 Growth Inhibition Assay IC50<0.005 μM 24009064
HCC1569 Growth Inhibition Assay IC50<0.005 μM 24009064
EFM-192A Growth Inhibition Assay IC50<0.005 μM 24009064
BT-474 Growth Inhibition Assay IC50<0.005 μM 24009064
MDAMB453 Growth Inhibition Assay IC50=1.59 ± 0.179 μM 23816254
KB Growth Inhibition Assay IC50=4.13 ± 0.47 μM 22491935
KBv200 Growth Inhibition Assay IC50=6.03 ± 0.64 μM 22491935
MCF-7 Growth Inhibition Assay IC50=3.30 ± 0.41 μM 22491935
MCF-7/Adr Growth Inhibition Assay IC50= 2.88 ± 0.30 μM 22491935
MCF-7 Growth Inhibition Assay IC50=3.02 ± 0.34 μM 22491935
MCF-7/FLV1000 Growth Inhibition Assay IC50=7.09 ± 0.71 μM 22491935
HL60 Growth Inhibition Assay IC50=2.26 ± 0.23 μM 22491935
HL60/Adr Growth Inhibition Assay IC50=1.42 ± 0.15 μM 22491935
HEK293/pcDNA3.1 Growth Inhibition Assay IC50=5.29 ± 0.53 μM 22491935
HEK293/ABCB1 Growth Inhibition Assay IC50=6.91 ± 0.70 μM 22491935
L858R(EGFR) Cell Viability Assay decreases cell viability in time and dose dependent manner 17311002
L858R/T790M(EGFR) Cell Viability Assay decreases cell viability in time and dose dependent manner 17311002
G776insV_G/C Cell Viability Assay decreases cell viability in time and dose dependent manner 17311002
wild-type Cell Viability Assay decreases cell viability in time and dose dependent manner 17311002
A775insYVMA Cell Viability Assay decreases cell viability in time and dose dependent manner 17311002
G776insV_G/L Cell Viability Assay decreases cell viability in time and dose dependent manner 17311002
P780insGSP Cell Viability Assay decreases cell viability in time and dose dependent manner 17311002
NCI-H1781 Growth Inhibition Assay inhibits cell growth in time and dose dependent manner 16818618
HCC827 Growth Inhibition Assay inhibits cell growth in time and dose dependent manner 16818618
H3255 Growth Inhibition Assay inhibits cell growth in time and dose dependent manner 16818618
NCI-H1975 Growth Inhibition Assay inhibits cell growth in time and dose dependent manner 16818618
A549 Growth Inhibition Assay inhibits cell growth in time and dose dependent manner 16818618
3T3 Growth Inhibition Assay IC50=700 ± 78 nM 15173008
3T3/neu Growth Inhibition Assay IC50=3 ± 0.14 nM 15173008
SK-Br-3 Growth Inhibition Assay IC50=2 ± 0.18 nM 15173008
BT 474 Growth Inhibition Assay IC50=2 ± 0.06 nM 15173008
A431 Growth Inhibition Assay IC50=81 ± 9 nM 15173008
MDA-MB-435 Growth Inhibition Assay IC50=960 ± 165 nM 15173008
SW620 Growth Inhibition Assay IC50=690 ± 84 nM 15173008
SKBR3 Function assay Inhibition of human Her2 in SKBR3 cells, EC50 = 0.002 μM. 18077425
BT474 Function assay Inhibition of human Her2 in BT474 cells, EC50 = 0.002 μM. 18077425
A431 Function assay Inhibition of human Her2 in A431 cells, EC50 = 0.081 μM. 18077425
SW620 Function assay Inhibition of human Her2 in SW620 cells, EC50 = 0.69 μM. 18077425
BA/F3 Cytotoxicity assay Cytotoxicity against mouse BA/F3 cells expressing EGFR L858R mutant, IC50 = 0.0035 μM. 19239229
BA/F3 Cytotoxicity assay Cytotoxicity against mouse BA/F3 cells expressing EGFR L858R/T790M mutant, IC50 = 0.18 μM. 19239229
他の多くの細胞株試験データをご覧になる場合はこちらをクリックして下さい

生物活性

製品説明 Neratinib is a highly selective HER2 and EGFR inhibitor with IC50 of 59 nM and 92 nM in cell-free assays; weakly inhibits KDR and Src, no significant inhibition to Akt, CDK1/2/4, IKK-2, MK-2, PDK1, c-Raf and c-Met. Phase 3.
Targets
HER2 [1]
(Cell-free assay)
EGFR [1]
(Cell-free assay)
KDR [1]
(Cell-free assay)
Src [1]
(Cell-free assay)
59 nM 92 nM 800 nM 1.4 μM
In Vitro
In vitro Neratinib weakly inhibits tyrosine kinases KDR and Src with IC50 of 0.8 μM and 1.4 μM, respectively, being 14- and 24-fold less active compared with HER2. Neratinib displays no activity against other serine-threonine kinases such as Akt, cyclin D1/cdk4, cyclin E/cdk2, cyclin B1/cdk1, IKK-2, MK-2, PDK1, c-Raf, and Tpl-2, as well as the tyrosine kinase c-Met. Neratinib selectively inhibits the proliferation of 3T3 cells transfected with the HER2 (3T3/neu), as well as two other HER-2-overexpressing SK-Br-3 and BT474 cells with IC50 values of 2-3 nM, displaying >230-fold potency compared with non-transfected 3T3 cells as well as MDA-MB-435 and SW620 which are EGFR- and HER2-negative. Neratinib also inhibits the proliferation of EGFR-dependent A431 cells with an IC50 of 81 nM. Neratinib reduces HER2 receptor autophosphorylation in BT474 cells with an IC50 of 5 nM, and EGF-dependent phosphorylation of EGFR in A431 cells with IC50 of 3 nM. Blocking of HER-2 by Neratinib results in inhibition of downstream MAPK and Akt pathways with IC50 of 2 nM, more potently than Trastuzumab. Neratinib inhibits the cyclin D1 expression and the phosphorylation of the Rb-susceptibility gene production in BT474 cells with IC50 of 9 nM, leading to G1-S arrest and ultimately decreased cell proliferation. [1]
Kinase Assay Cell-free autophosphorylation assay using time-resolved fluorometry
Neratinib is prepared as 10 mg/mL stocks in DMSO and diluted in 25 mM HEPES (pH 7.5; 0.002 ng/mL-20 μg/mL). Purified recombinant COOH-terminal fragments of HER2 (amino acids 676-1255) or epidermal growth factor receptor (EGFR) (amino acids 645-1186) [diluted in 100 mM HEPES (pH 7.5) and 50% glycerol] is incubated with increasing concentrations of Neratinib in 4 mM HEPES (pH 7.5), 0.4 mM MnCl2, 20 μM sodium vanadate, and 0.2 mM DTT for 15 minutes at room temperature in 96-well ELISA plates. The kinase reaction is initiated by the addition of 40 μM ATP and 20 mM MgCl2 and allowed to proceed for 1 hour at room temperature. Plates are washed, and phosphorylation is detected using Europium-labeled anti-phospho-tyrosine antibodies (15 ng/well). After washing and enhancement steps, signal is detected using a Victor2 fluorescence reader (excitation wavelength 340 nm, emission wavelength 615 nm). The concentration of Neratinib that inhibits receptor phosphorylation by 50% (IC50) is calculated from inhibition curves.
細胞実験 細胞株 3T3, 3T3/neu, A431, BT474, SK-Br-3, MDA-MB-435, and SW480
濃度 Dissolved in DMSO, final concentrations 0.5 ng/mL-5 μg/mL
反応時間 2 or 6 days
実験の流れ Cells are exposed to various concentrations of Neratinib for 2, or 6 days. Cell proliferation is determined using sulforhodamine B, a protein binding dye. Briefly, cells are fixed with 10% trichloroacetic acid and washed extensively with water. Cells are then stained with 0.1% sulforhodamine B and washed in 5% acetic acid. Protein-associated dye is solubilized in 10 mM Tris, and absorbance is measured at 450 nM. The concentration of Neratinib that inhibits cell proliferation by 50% (IC50) is determined from inhibition curves.
実験結果図 Methods Biomarkers 結果図 PMID
Western blot p-ERBB2 / ERBB2 / p-ERBB3 / ERBB3 / p-EGFR / p-90RSK pHER2 / HER2 / pAKT / AKT / pERK / ERK 30118499
Growth inhibition assay Cell viability 30118499
In Vivo
In Vivo Oral administration of Neratinib significantly inhibits the growth of 3T3/neu xenografts, with inhibition of 34%, 53%, 98%, and 98% at dose of 10, 20, 40, and 80 mg/kg/day, respectively. Consistent with the inhibition of HER-2 phosphorylation by 84% within 1 hour of administration at 40 mg/kg/day, Neratinib inhibits the growth of BT474 xenografts by 70-82%, 67%, and 93% at dose of 5, 10, and 40 mg/kg/day, respectively. Neratinib is also effective against SK-OV-3 xenografts with inhibition of 31% and 85% at 5 and 60 mg/kg/day, respectively. Neratinib is less potent against EGFR-dependent A431 xenografts than HER-2-dependent tumors, with 32% and 44% inhibition at 5 and 20 mg/kg/day, respectively. Neratinib displays little activity against MCF-7 and MX-1 xenografts expressing low levels of HER-2 and EGFR, with only 28% inhibition at 80 mg/kg/day, suggesting that Neratinib has selective activity for cells expressing HER-2 or EGFR. [1]
動物実験 動物モデル Female athymic (nude) mice implanted s.c. with 3T3/neu, BT474, MCF-7, or SK-OV-3 cells
投与量 ~80 mg/kg/day
投与経路 Gavage
NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT05388149 Recruiting
Breast Cancer|HER2-positive Breast Cancer
University Health Network Toronto
December 6 2022 Phase 2
NCT05252988 Recruiting
Early-stage Breast Cancer|HER2 Positive Breast Cancer|Hormone Receptor Positive
Spanish Breast Cancer Research Group|Puma Biotechnology Inc.|Pierre Fabre Laboratories
August 31 2022 Phase 2
NCT04856475 Withdrawn
Breast Cancer|Brain Metastases
Jules Bordet Institute
November 24 2021 Phase 2
NCT04781374 Withdrawn
Metastatic Prostate Adenocarcinoma|Castration-resistant Prostate Cancer|Prostate Cancer|Prostate Cancer Metastatic
Beth Israel Deaconess Medical Center|Puma Biotechnology Inc.|Dana-Farber Cancer Institute
May 21 2021 Phase 2

化学情報

分子量 557.04 化学式

C30H29ClN6O3

CAS No. 698387-09-6 SDF Download Neratinib SDFをダウンロードする
Smiles CCOC1=C(C=C2C(=C1)N=CC(=C2NC3=CC(=C(C=C3)OCC4=CC=CC=N4)Cl)C#N)NC(=O)C=CCN(C)C
保管

In vitro
Batch:

DMSO : 6 mg/mL ( (10.77 mM); Warmed with 50℃ water bath; 吸湿したDMSOは溶解度を減少させます。新しいDMSOをご使用ください。)

Water : Insoluble

Ethanol : Insoluble

モル濃度計算器

in vivo
Batch:

Add solvents to the product individually and in order.

投与溶液組成計算機

実験計算

モル濃度計算器

質量 濃度 体積 分子量

投与溶液組成計算機(クリア溶液)

ステップ1:実験データを入力してください。(実験操作によるロスを考慮し、動物数を1匹分多くして計算・調製することを推奨します)

mg/kg g μL

ステップ2:投与溶媒の組成を入力してください。(ロット毎に適した溶解組成が異なる場合があります。詳細については弊社までお問い合わせください)

% DMSO % % Tween 80 % ddH2O
%DMSO %

計算結果:

投与溶媒濃度: mg/ml;

DMSOストック溶液調製方法: mg 試薬を μL DMSOに溶解する(濃度 mg/mL, 注:濃度が当該ロットのDMSO溶解度を超える場合はご連絡ください。 )

投与溶媒調製方法:Take μL DMSOストック溶液に μL PEG300,を加え、完全溶解後μL Tween 80,を加えて完全溶解させた後 μL ddH2O,を加え完全に溶解させます。

投与溶媒調製方法:μL DMSOストック溶液に μL Corn oil,を加え、完全溶解。

注意:1.ストック溶液に沈殿、混濁などがないことをご確認ください;
2.順番通りに溶剤を加えてください。次のステップに進む前に溶液に沈殿、混濁などがないことを確認してから加えてください。ボルテックス、ソニケーション、水浴加熱など物理的な方法で溶解を早めることは可能です。

技術サポート

ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

Handling Instructions

他に質問がある場合は、お気軽にお問い合わせください。

* 必須

大学・企業名を記入してください
名前を記入してください
電子メール・アドレスを記入してください 有効なメールアドレスを入力してください
お問い合わせ内容をご入力ください
Tags: Neratinibを買う | Neratinib ic50 | Neratinib供給者 | Neratinibを購入する | Neratinib費用 | Neratinib生産者 | オーダーNeratinib | Neratinib化学構造 | Neratinib分子量 | Neratinib代理店